|
2009-04-03 |
2009-04-02 |
S
Sale
|
SPIEGELMAN DANIEL K
SVP, CFO
Officer
|
69,637
-48.7%
19.91
USD 1,386,473
|
69,637
-48.7%
|
19.91
|
USD 1,386,473
|
|
|
2009-04-03 |
2009-04-02 |
S
Sale
|
SPIEGELMAN DANIEL K
SVP, CFO
Officer
|
11,969
-21.3%
19.91
USD 238,303
|
11,969
-21.3%
|
19.91
|
USD 238,303
|
|
|
2009-04-03 |
2009-04-02 |
S
Sale
|
SPIEGELMAN DANIEL K
SVP, CFO
Officer
|
59,423
-59.1%
19.91
USD 1,183,112
|
59,423
-59.1%
|
19.91
|
USD 1,183,112
|
|
|
2009-04-03 |
2009-04-02 |
S
Sale
|
LANGE LOUIS G
Chairman & CEO
Executive Director
|
278,477
-35.6%
19.90
USD 5,541,692
|
278,477
-35.6%
|
19.90
|
USD 5,541,692
|
|
|
2009-04-03 |
2009-04-02 |
S
Sale
|
LANGE LOUIS G
Chairman & CEO
Executive Director
|
16,154
-4.0%
19.90
USD 321,465
|
16,154
-4.0%
|
19.90
|
USD 321,465
|
|
|
2009-04-03 |
2009-04-02 |
S
Sale
|
LANGE LOUIS G
Chairman & CEO
Executive Director
|
45,929
-10.7%
19.90
USD 913,987
|
45,929
-10.7%
|
19.90
|
USD 913,987
|
|
|
2009-04-03 |
2009-04-02 |
S
Sale
|
LANGE LOUIS G
Chairman & CEO
Executive Director
|
138,615
-26.8%
19.90
USD 2,758,439
|
138,615
-26.8%
|
19.90
|
USD 2,758,439
|
|
|
2008-12-10 |
2008-12-10 |
PS
Planned sale
|
STUART LEWIS J
SVP COMMERCIAL OPERATIONS
Officer
|
1,002
-7.0%
9.23
USD 9,248
|
1,002
-7.0%
|
9.23
|
USD 9,248
|
|
|
2008-12-10 |
2008-11-20 |
S
Sale
|
STUART LEWIS J
SVP COMMERCIAL OPERATIONS
Officer
|
2,000
-14.7%
8.19
USD 16,380
|
2,000
-14.7%
|
8.19
|
USD 16,380
|
|
|
2008-10-15 |
2008-10-14 |
PS
Planned sale
|
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Officer
|
2,000
-6.6%
8.93
USD 17,860
|
2,000
-6.6%
|
8.93
|
USD 17,860
|
|
|
2008-08-01 |
2008-07-31 |
PS
Planned sale
|
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Officer
|
12,500
-26.8%
9.50
USD 118,750
|
12,500
-26.8%
|
9.50
|
USD 118,750
|
|
|
2008-04-29 |
2008-04-25 |
PS
Planned sale
|
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Officer
|
12,500
-25.6%
9.51
USD 118,875
|
12,500
-25.6%
|
9.51
|
USD 118,875
|
|
|
2008-01-10 |
2008-01-10 |
PS
Planned sale
|
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Officer
|
10,000
-22.9%
9.50
USD 95,000
|
10,000
-22.9%
|
9.50
|
USD 95,000
|
|
|
2007-12-20 |
2007-12-18 |
S
Sale
|
GUTSHALL THOMAS L
Non-Executive Director
|
7,500
-60.0%
9.01
USD 67,560
|
7,500
-60.0%
|
9.01
|
USD 67,560
|
|
|
2007-12-12 |
2007-12-11 |
PS
Planned sale
|
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Officer
|
3,951
-11.5%
9.63
USD 38,048
|
3,951
-11.5%
|
9.63
|
USD 38,048
|
|
|
2007-12-12 |
2007-12-11 |
PS
Planned sale
|
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Officer
|
15,000
-30.4%
9.74
USD 146,100
|
15,000
-30.4%
|
9.74
|
USD 146,100
|
|
|
2007-12-11 |
2007-12-10 |
PS
Planned sale
|
SPIEGELMAN DANIEL K
SVP, CFO
Officer
|
8,000
-46.4%
10.03
USD 80,240
|
8,000
-46.4%
|
10.03
|
USD 80,240
|
|
|
2007-11-13 |
2007-11-09 |
PS
Planned sale
|
STUART LEWIS J
SVP COMMERCIAL OPERATIONS
Officer
|
2,497
-31.7%
10.19
USD 25,444
|
2,497
-31.7%
|
10.19
|
USD 25,444
|
|
|
2007-08-17 |
2007-08-16 |
S
Sale
|
BLACKBURN BRENT K
SVP, Drug Discovery & Dev
Officer
|
10,000
-30.2%
10.09
USD 100,900
|
10,000
-30.2%
|
10.09
|
USD 100,900
|
|
|
2007-01-18 |
2007-01-17 |
PS
Planned sale
|
SPIEGELMAN DANIEL K
SVP, CFO
Officer
|
7,000
-61.5%
13.93
USD 97,510
|
7,000
-61.5%
|
13.93
|
USD 97,510
|
|
